Jafron Biomedical Co Ltd 300529.SZ

Last Updated: May 15, 12:00 AM·SZSE

Jafron Biomedical Co Ltd

Jafron Biomedical Co Ltd. Stock Analysis 300529.SZ

China Health Care Mid Cap
Jafron Biomedical Co., Ltd. engages in the research, development, production, and sale of hemoperfusion products. The company is headquartered in Zhuhai, Guangdong and currently employs 2,301 full-time employees. The company went IPO on 2016-08-02. The firm is mainly engaged in the provision of disposable blood perfusion device, disposable plasma bilirubin adsorber, deoxyribonucleic acid (DNA) immunosorbent columns, cytokine adsorption column, haemodialysis powder, blood purification equipment and other products. The firm's products are widely used in the treatment of uremia, poisoning, severe liver disease, autoimmune diseases and multi-organ failure. The firm mainly conducts its businesses in the domestic market and overseas markets.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.